Aureomycin A-377
Brand names,
Aureomycin A-377
Analogs
Aureomycin A-377
Brand Names Mixture
Aureomycin A-377
Chemical_Formula
C22H23ClN2O8
Aureomycin A-377
RX_link
No information avaliable
Aureomycin A-377
fda sheet
Aureomycin A-377
msds (material safety sheet)
Aureomycin A-377
Synthesis Reference
No information avaliable
Aureomycin A-377
Molecular Weight
478.879 g/mol
Aureomycin A-377
Melting Point
No information avaliable
Aureomycin A-377
H2O Solubility
Soluble (at all physiological pH values)
Aureomycin A-377
State
Solid
Aureomycin A-377
LogP
0.315
Aureomycin A-377
Dosage Forms
Capsules
Aureomycin A-377
Indication
For the treatment of infections and to treat acne. It may also be used to treat urinary tract infections, gum disease, and other bacterial infections such as gonorrhea and chlamydia. Lymecycline is also used commonly as a prophylactic treatment for infection by Bacillus anthracis (anthrax). It is also effective against Yersinia pestis and malaria and is also prescribed for the treatment of Lyme disease.
Aureomycin A-377
Pharmacology
Lymecycline is a tetracycline broad-spectrum antibiotic. It is approximately 5000 times more soluble than tetracycline base and is unique amongst tetracyclines in that it is absorbed by the "active transport" process across the intestinal wall, making use of the same fast and efficient mechanism by which carbohydrates are absorbed. It inhibits cell growth by inhibiting translation.
Aureomycin A-377
Absorption
Absorption is fast and efficient. Bioavailability is 100% following oral administration.
Aureomycin A-377
side effects and Toxicity
Adverse effects include nausea, vomiting, diarrhoea, glossitis, enterocolitis, dysphagia, dermatitis, hypersensitivity reactions, proctitis, and vaginitis.
Aureomycin A-377
Patient Information
Aureomycin A-377
Organisms Affected
Enteric bacteria and other eubacteria